Skip to main content
. Author manuscript; available in PMC: 2023 Aug 21.
Published in final edited form as: J Alzheimers Dis. 2023;93(3):1095–1109. doi: 10.3233/JAD-221167

Table 1.

Newcastle Ottawa Scale Risk of Bias Assessment

Study Selection Comparability Outcome or Exposure Total
Case-Control Studies
Alavez-Rubio 2020 [33] *** ** ** 7
Arboleda 2001 [24] ** ** * 5
Bartrés-Faz 2001 [34] **** * 5
Campos 2013 [5] *** ** * 6
Jacquier 2001 [21] *** ** * 6
Cristiá-Lara 2017 [35] **** ** ** 8
Forero 2006 [22] *** ** * 6
Mateo 2002 [37] **** * 5
Moreno 2017 [23] **** ** ** 8
Sevush 2000 [29] **** * * 6
Teruel 2011 [36] **** ** ** 8
Villalpando-Berumen 2008 [31] **** ** * 7
Marca-Ysabel 2021 [25] **** ** * 7
Aguilar-Navarro 2021 [32] *** ** * 6
Cohort Studies
Granot-Hershkovitz 2020 [6] *** ** * 6
Allegri 2018 [27] **** ** ** 8
Molero 2001 [26] **** ** * 7
Villarreal 2016 [38] **** ** ** 8
O'Bryant 2013 [28] **** ** ** 8
Tosto 2015 [30] *** ** ** 7

Newcastle-Ottawa-Scale scores for the risk of bias assessment of included studies.

Case-Control: Selection (max 4 stars): (1) Is the case definition adequate? (2) Representativeness of the cases (3) Selection of Controls (4) Definition of Controls Comparability (max 2 stars): (1) Comparability of cases and controls on the basis of the design or analysis- A. study controls for the most important factor (*) B. study controls for any additional factor (*) Exposure (max 3 stars): (1) Ascertainment of exposure (2) Same method of ascertainment for cases and controls (3) Non-response rate

Cohort: Selection (max 4 stars): (1) Representativeness of the exposed cohort (2) Selection of the non-exposed cohort (3) Ascertainment of exposure (4) Demonstration that outcome of interest was not present at start of study Comparability (max 2 stars): (1) Comparability of cohorts on the basis of the design or analysis- A. study controls for the most important factor (*) B. study controls for any additional factor (*) Outcome (max 3 stars): (1) Assessment of outcome (2) Was follow-up >5 years (3) Adequacy of follow up of cohorts